Lymphoma Current Events | Lymphoma News | 2
|
| Page
2 of
7 |
128 Results |
|
|
|
Sort By:
Page Views | Date |
Study shows that maintenance rituximab is useful for advanced indolent lymphoma
A new study has found for the first time that maintenance therapy with the novel antibody, rituximab (MR) following cyclophosphamide, vincristine and prednisone (CVP) therapy improves progression-free survival in patients with stage III-IV indolent lymphoma. view more (2009-03-11)
Cutaneous T-Cell Lymphoma On The Rise, VA/Brown Research Shows
Cutaneous T-cell lymphoma, a rare and mysterious cancer, is on the rise, according to the first nationwide study of the disease in a decade. view more (2007-07-17)
Hepatitis C increases risk of non-Hodgkin lymphoma
Hepatitis C infection is associated with an increased risk of non-Hodgkin lymphoma (malignancy involving lymphatic tissue) of 20 percent to 30 percent, and a three-fold increase in the risk of another type of lymphoma, according to a study in the May 9 issue of JAMA. view more (2007-05-09)
UC Davis researchers report new molecule that targets leukemia and lymphoma cells
UC Davis Cancer Center researchers have developed a novel peptide that binds to the surface of leukemia and lymphoma cells with extremely high affinity, specificity and stability, and demonstrates remarkable promise as a tool to help image tumors and deliver anti-cancer drugs. view more (2006-06-13)
Rates of cutaneous T-cell lymphoma increase over 30 years
The cancer known as cutaneous T-cell lymphoma became substantially more common in the United States between 1973 and 2002, according to a report in the July issue of Archives of Dermatology, one of the JAMA/Archives journals. view more (2007-07-17)
Adding epratuzumab to standard therapy
Adding a second monoclonal antibody drug to chemotherapy looks promising for treatment of diffuse large B-cell lymphoma. view more (2008-05-16)
USC researchers identify DNA mutation that occurs at beginning point of T-cell lymphoma
Researchers at the Keck School of Medicine of the University of Southern California (USC) have identified a key mechanism that causes chromosomes within blood cells to break-an occurrence that marks the first step in the development of human lymphoma. view more (2009-06-12)
Attention: Extra-hepatic manifestation of hepatitis C virus infection
In 1994, the team of Tchernev and Petrova from Alexandrovska Hospital in Sofia examined a female patient with liver cirrhosis caused by chronic Hepatitis C virus (HCV). view more (2008-01-17)
Signal molecule holds possible key to tumour growth
Immunity to a cancer in chickens could shed light on ways to control certain human cancers according to scientists from the Institute for Animal Health (IAH). Their work on Marek's disease (MD) in chickens has identified the first natural model for specific Hodgkin's and non-Hodgkin's lymphomas, and is published this week in PNAS (06-10 September... view more... (2004-09-06)
Lombardi Expert Helps Set New Guidelines for Assessing Lymphoma Treatment
An international team of cancer specialists and imaging experts, including Bruce Cheson, professor of medicine, head of hematology, and director of hematology research at Georgetown's Lombardi Comprehensive Cancer Center, has developed standardized guidelines for assessing how lymphomas respond to treatment. view more (2007-02-07)
Study establishes new class of cancer-causing genes
Over the past few years, scientists have discovered that a new class of genetic regulators called "microRNAs" influences normal human growth and development. Now, researchers have found that microRNAs also play an important role in human cancer. view more (2005-06-08)
Rheb's role in cancer
Two independent papers in the August 15th issue of G&D identify the Rheb GTPase as a novel oncogene and a promising new chemotherapeutic target. view more (2008-08-15)
Risk of lymphoma increases with hepatitis C virus infection
People infected with the hepatitis C virus (HCV) are at an increased risk of developing certain lymphomas (cancers of the lymphatic system), according to a study published in the May 8, 2007, issue of the Journal of the American Medical Association. view more (2007-05-09)
Immunotherapy demonstrates long-term success in treating lymphoma
Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue. New study results demonstrate high success rates using specialized white blood cells to prevent or treat lymphoma associated with the Epstein-Barr virus... view more... (2009-11-02)
Allergy - cancer link
Some allergic conditions could increase your risk of suffering from blood cancer as an adult, according to a new study published this week in BMC Public Health. This is important news for the increasingly large numbers of allergy sufferers worldwide. view more (2004-11-03)
Novel test identifies lymphoma patients likely to respond to new therapy
Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who'll be most likely to... view more... (2007-02-21)
New cancer target for non-Hodgkin's lymphoma
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. view more (2009-11-23)
Identifying Lymphoma Risks
Little is known about the causes of lymphoma. A case-control study conducted by Professor Nikolaus Becker and Dr. Alexandra Nieters, Division of Clinical Epidemiology at the Deutsches Krebsforschungszentrum (German Cancer Research Center, DKFZ), is looking closely at possible risk factors. First results of this German lymphoma study suggest... view more... (2004-09-14)
Silencing small but mighty cancer inhibitors
Researchers from Johns Hopkins and the University of Pennsylvania have uncovered another reason why one of the most commonly activated proteins in cancer is in fact so dangerous. view more (2007-12-11)
'Allergy cells' can aggravate cancer and psoriasis
The body's mast cells are mainly associated with allergic reaction in the way they release histamine and other inflammatory substances. view more (2006-09-11)
|
|
| Page
2 of
7 |
128 Results |
|
|
|
Sort By:
Page Views | Date |
|
